Journal of Nutrients

Published by: Asian Medical Journals
Online ISSN: 2410-6542
Print ISSN: 2413-8428
Total Citations: 15
Quick Submission    Login/Submit/Track

No. 2

The Effect of Regular Hazelnut Consumption on Cardiovascular Risk Factors and Acceptance in Māori and European

Pages: 39-53
Find References

Finding References


The Effect of Regular Hazelnut Consumption on Cardiovascular Risk Factors and Acceptance in Māori and European

Search :
Google Scholor
Search :
Microsoft Academic Search
Cite

DOI: 10.18488/journal.87/2015.2.2/87.2.39.53

Citation: 4

Siew Ling Tey , Terryn Robinson , Heniti Davis , Andrew R Gray , Alexandra W Chisholm , Rachel C Brown

Export to    BibTeX   |   EndNote   |   RIS

  1. J. L. Browne and D. E. Grobbee, "Cardiovascular prevention and international health: Time for action," Eur. J. Cardiovasc. Prev. Rehabil., vol. 18, pp. 547-549, 2011.
  2. B. Robson and R. Harris, Hauora: M?ori standards of health IV. A study of the years 2000-2005. Wellington: Te R?p? Rangahau Hauora a Eru P?mare, 2007.
  3. New Zealand Ministry of Health, Tatau Kahukura: Maori health chart book 2010, 2nd ed. Wellington: Ministry of Health, 2010.
  4. E. Ros, "Health benefits of nut consumption," Nutrients, vol. 2, pp. 652-682, 2010.
  5. J. Sabate and Y. Ang, "Nuts and health outcomes: New epidemiologic evidence," Am. J. Clin. Nutr., vol. 89, pp. S1643-S1648, 2009.
  6. A. Afshin, R. Micha, S. Khatibzadeh, and D. Mozaffarian, "Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: A systematic review and meta-analysis," Am. J. Clin. Nutr., vol. 100, pp. 278-288, 2014.
  7. D. K. Banel and F. B. Hu, "Effects of walnut consumption on blood lipids and other cardiovascular risk factors: A meta-analysis and systematic review," Am. J. Clin. Nutr., vol. 90, pp. 56-63, 2009.
  8. A. Chisholm, K. McAuley, J. Mann, S. Williams, and M. Skeaff, "Cholesterol lowering effects of nuts compared with a canola oil enriched cereal of similar fat composition," Nutr. Metab. Cardiovasc. Dis., vol. 15, pp. 284-292, 2005.
  9. S. K. Gebauer, S. G. West, C. D. Kay, P. Alaupovic, D. Bagshaw, and P. M. Kris-Etherton, "Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: A dose-response study," Am. J. Clin. Nutr., vol. 88, pp. 651-659, 2008.
  10. G. A. Spiller, A. Miller, K. Olivera, J. Reynolds, B. Miller, S. J. Morse, A. Dewell, and J. W. Farquhar, "Effects of plant-based diets high in raw or roasted almonds, or roasted almond butter on serum lipoproteins in humans," J. Am. Coll. Nutr., vol. 22, pp. 195-200, 2003.
  11. S. L. Tey, R. C. Brown, A. W. Chisholm, C. M. Delahunty, R. Gray, and S. M. Williams, "Effects of different forms of hazelnuts on blood lipids and ?-tocopherol concentrations in mildly hypercholesterolemic individuals," Eur. J. Clin. Nutr., vol. 65, pp. 117-124, 2011.
  12. P. Casas-Agustench, M. Bullo, and J. Salas-Salvado, "Nuts, inflammation and insulin resistance," Asia Pac. J. Clin. Nutr., vol. 19, pp. 124-30, 2010.
  13. E. Ros, "Nuts and novel biomarkers of cardiovascular disease," Am. J. Clin. Nutr., vol. 89, pp. S1649-S1656, 2009.
  14. C. M. Alper and R. D. Mattes, "Effects of chronic peanut consumption on energy balance and hedonics," Int. J. Obes. Relat. Metab. Disord., vol. 26, pp. 1129-1137, 2002.
  15. G. E. Fraser, H. W. Bennett, K. B. Jaceldo, and J. Sabate, "Effect on body weight of a free 76 kilojoule (320 Calorie) daily supplement of almonds for six months," J. Am. Coll. Nutr., vol. 21, pp. 275-283, 2002.
  16. J. Hollis and R. Mattes, "Effect of chronic consumption of almonds on body weight in healthy humans," Br. J. Nutr., vol. 98, pp. 651-656, 2007.
  17. J. Sabate, Z. Cordero-MacIntyre, G. Siapco, S. Torabian, and E. Haddad, "Does regular walnut consumption lead to weight gain?," Br. J. Nutr., vol. 94, pp. 859-864, 2005.
  18. S. L. Tey, R. Brown, A. Gray, A. Chisholm, and C. Delahunty, "Nuts improve diet quality compared to other energy-dense snacks while maintaining body weight," J. Nutr. Metab., vol. 2011, p. 357350, 2011.
  19. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand, "National heart foundation of Australia and the cardiac society of Australia and New Zealand: Position statement on lipid management - 2005," Heart Lung Circ., vol. 144, pp. 275-291, 2005.
  20. F. McKiernan, P. Lokko, A. Kuevi, R. L. Sales, N. M. Costa, J. Bressan, R. C. Alfenas, and R. D. Mattes, "Effects of peanut processing on body weight and fasting plasma lipids," Br. J. Nutr., vol. 104, pp. 418-26, 2010.
  21. S. L. Tey, R. Brown, A. Chisholm, A. Gray, S. Williams, and C. Delahunty, "Current guidelines for nut consumption are achievable and sustainable: A hazelnut intervention," Br. J. Nutr., vol. 105, pp. 1503-1511, 2011.
  22. S. L. Tey, R. C. Brown, A. R. Gray, A. W. Chisholm, and C. M. Delahunty, "Long-term consumption of high energy-dense snack foods on sensory-specific satiety and intake," Am. J. Clin. Nutr., vol. 95, pp. 1038-1047, 2012.
  23. S. L. Tey, C. Delahunty, A. Gray, A. Chisholm, and R. C. Brown, "Effects of regular consumption of different forms of almonds and hazelnuts on acceptance and blood lipids," Eur. J. Nutr. Doi: 10.1007/s00394-014-0808-7, 2014.
  24. S. L. Tey, A. R. Gray, A. W. Chisholm, C. M. Delahunty, and R. C. Brown, "The dose of hazelnuts influences acceptance and diet quality but not inflammatory markers and body composition in overweight and obese individuals," J. Nutr., vol. 143, pp. 1254-1262, 2013.
  25. S. Tey, R. Brown, and A. Chisholm, Nuts and heart health. National heart foundation of New Zealand evidence-based position statement on the relationship of nuts to heart health. Auckland, New Zealand: National Heart Foundation of New Zealand, 2012.
  26. R. Marshall, Diet entry and storage, diet cruncher. In a batch processing diet analysis system for the PC. Nutricomp: Dunedin, 2003.
  27. N. Athar, J. McLaughlin, G. Taylor, and S. Mishra, The concise New Zealand food composition tables. Palmerston North: Plant and food research, 7th ed. Wellington: Ministry of Health, 2006.
  28. G. Assmann, H. Schriewer, G. Schmitz, and E. O. Hagele, "Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2," Clin. Chem., vol. 29, pp. 2026-2030, 1983.
  29. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge," Clin. Chem., vol. 18, pp. 499-502, 1972.
  30. P. M. Kris-Etherton, S. Yu-Poth, J. Sabate, H. E. Ratcliffe, G. Zhao, and T. D. Etherton, "Nuts and their bioactive constituents: Effects on serum lipids and other factors that affect disease risk," Am J Clin Nutr., vol. 70, pp. S504-S511, 1999b.
  31. R. Segura, C. Javierre, M. A. Lizarraga, and E. Ros, "Other relevant components of nuts: Phytosterols, folate and minerals," Br. J. Nutr., vol. 96, pp. S36-S44, 2006.
  32. S. Torabian, E. Haddad, Z. Cordero-MacIntyre, J. Tanzman, M. L. Fernandez, and J. Sabate, "Long-term walnut supplementation without dietary advice induces favorable serum lipid changes in free-living individuals," Eur. J. Clin. Nutr., vol. 64, pp. 274-9, 2010.
  33. J. Sabate, K. Oda, and E. Ros, "Nut consumption and blood lipid levels: A pooled analysis of 25 intervention trials," Arch. Intern. Med., vol. 170, pp. 821-827, 2010.
  34. L. Djousse, T. Rudich, and J. M. Gaziano, "Nut consumption and risk of hypertension in US male physicians," Clin. Nutr., vol. 28, pp. 10-14, 2009.
  35. S. Blanco Mejia, C. W. Kendall, E. Viguiliouk, L. S. Augustin, V. Ha, A. I. Cozma, A. Mirrahimi, A. Maroleanu, L. Chiavaroli, L. A. Leiter, R. J. De Souza, D. J. Jenkins, and J. L. Sievenpiper, "Effect of tree nuts on metabolic syndrome criteria: A systematic review and meta-analysis of randomised controlled trials," BMJ Open, vol. 4, p. e004660, 2014.
  36. P. Casas-Agustench, P. Lopez-Uriarte, E. Ros, M. Bullo, and J. Salas-Salvado, "Nuts, hypertension and endothelial function," Nutr. Metab. Cardiovasc. Dis., vol. 21, pp. S21-S33, 2011.
  37. P. Casas-Agustench, P. López-Uriarte, M. Bulló, E. Ros, J. J. Cabré-Vila, and J. Salas-Salvadó, "Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome," Nutr. Metab. Cardiovasc. Dis., vol. 21, pp. 126-135, 2011.
  38. N. R. T. Damasceno, A. Perez-Heras, M. Serra, M. Cofan, A. Sala-Vila, J. Salas-Salvado, and E. Ros, "Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers," Nutr. Metab. Cardiovasc. Dis., vol. 21, pp. S14-S20, 2011.
  39. D. J. A. Jenkins, C. W. C. Kendall, A. Marchie, T. L. Parker, P. W. Connelly, W. Qian, J. S. Haight, D. Faulkner, E. Vidgen, K. G. Lapsley, and G. A. Spiller, "Dose response of almonds on coronary heart disease risk factors: Blood lipids, oxidized low-density lipoproteins, lipoprotein (A), homocysteine, and pulmonary nitric oxide: A randomized, controlled, crossover trial," Circulation, vol. 106, pp. 1327-1332, 2002.
  40. S. Kalgaonkar, R. U. Almario, D. Gurusinghe, E. M. Garamendi, W. Buchan, K. Kim, and S. E. Karakas, "Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS," Eur. J. Clin. Nutr., vol. 65, pp. 386-393, 2011.
  41. S. B. Kurlandsky and K. S. Stote, "Cardioprotective effects of chocolate and almond consumption in healthy women," Nutr. Res., vol. 26, pp. 509-516, 2006.
  42. I. Ros, E. Nunez, A. Perez-Heras, M. Serra, R. Gilabert, E. Casals, and R. Deulofeu, "A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial," Circulation, vol. 109, pp. 1609-1614, 2004.
  43. I. Sari, Y. Baltaci, C. Bagci, V. Davutoglu, O. Erel, H. Celik, O. Ozer, N. Aksoy, and M. Aksoy, "Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: A prospective study," Nutrition, vol. 26, pp. 399-404, 2010.
  44. A. E. Schutte, J. M. Van Rooyen, H. W. Huisman, J. Mukuddem-Petersen, W. Oosthuizen, S. M. Hanekom, and J. C. Jerling, "Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome," Am. J. Hypertens, vol. 19, pp. 629-636, 2006.
  45. F. B. Yucesan, A. Orem, B. V. Kural, C. Orem, and I. Turan, "Hazelnut consumption decreases the susceptibility of LDL to oxidation, plasma oxidized LDL level and increases the ratio of large/small LDL in normolipidemic healthy subjects," Anadolu Kardiyol Derg., vol. 10, pp. 28-35, 2010.
  46. J. Mukuddem-Petersen, W. Stonehouse, J. C. Jerling, S. M. Hanekom, and Z. White, "Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: A controlled feeding trial," Br. J. Nutr., vol. 97, pp. 1144-1153, 2007.
  47. P. R. Ellis, C. W. C. Kendall, Y. Ren, C. Parker, J. F. Pacy, K. W. Waldron, and D. J. A. Jenkins, "Role of cell walls in the bioaccessibility of lipids in almond seeds," Am. J. Clin. Nutr., vol. 80, pp. 604-613, 2004.
  48. M. Grundy, T. Grassby, G. Mandalari, K. Waldron, B. PJ, S. Berry, and P. Ellis, "Effect of masticationon lipid bioaccessibility of almonds in a randomized human study and its implications for digestion kinetics, metabolizable energy, and postprandial lipemia," Am. J. Clin. Nutr. Doi: 10.3945/ajcn.114.088328, 2015.
  49. C. L. Jackson and F. B. Hu, "Long-term associations of nut consumption with body weight and obesity," Am. J. Clin. Nutr., vol. 100, pp. 408S-411S, 2014.
  50. J. A. Novotny, S. K. Gebauer, and D. J. Baer, "Discrepancy between the atwater factor predicted and empirically measured energy values of almonds in human diets," Am. J. Clin. Nutr., vol. 96, pp. 296-301, 2012.
  51. H. R. Moskowitz, "Engineering out food boredom: A product development approach that combines home use tests and time-preference analysis," Food Qual Prefer., vol. 11, pp. 445-456, 2000.
  52. Hodson, C.M. S. and J. E. McKenzie, "Maximal response to a plasma cholesterol- lowering diet is achieved within two weeks," Nutr. Metab. Cardiovasc. Dis., vol. 12, pp. 291-295, 2002.
Siew Ling Tey , Terryn Robinson , Heniti Davis , Andrew R Gray , Alexandra W Chisholm , Rachel C Brown (2015). The Effect of Regular Hazelnut Consumption on Cardiovascular Risk Factors and Acceptance in Māori and European. Journal of Nutrients, 2(2): 39-53. DOI: 10.18488/journal.87/2015.2.2/87.2.39.53
Aims Studies reporting reductions in heart disease risk with regular nut consumption comprise populations largely of European descent. Whether the healthful effects of nuts extend to other ethnic groups is largely unknown. This study compared the effects of consuming 30 g/d of hazelnuts on risk factors for cardiovascular disease (CVD) and acceptance amongst Māori and Europeans. 
Methods Twenty Māori and 19 European participants consumed 30 g/d of hazelnuts for 28 days. Plasma lipids and lipoproteins, apolipoproteins (apo), high sensitivity C-reactive protein (hs-CRP), blood pressure, dietary intake, and body weight were measured at baseline and at the end of the intervention. ‘Desire to consume’ and ‘overall liking’ for hazelnuts were assessed daily. Results There were no significant differences in the changes of any of the outcome measurements between Māori and Europeans (P≥0.145). Further, there were no significant changes among participants overall in biochemical indices, blood pressure, body weight, BMI, or body composition (P≥0.114) aside from systolic blood pressure which decreased by 3% (P=0.031) and hs-CRP which increased by 0.21 mg/dl (P=0.047) during the study. However, the hazelnut-enriched diet significantly increased energy, total fat, monounsaturated and polyunsaturated fat intake in study participants (all P≤0.006), with no changes for other nutrients (all P≥0.116) or difference between groups (all P≥0.513). ‘Desire to consume’ and ‘overall liking’ remained relatively stable over the 28-day intervention period. Conclusions There was no evidence of difference in effects on CVD risk factors between Māori and European following regular consumption of nuts. It appears both ethnic groups continued to like nuts and wished to consume them daily after consuming nuts for 28-days, suggesting adherence to guidelines to consume nuts regularly is achievable in both populations.

Contribution/ Originality
This study is one of very few studies, which have investigated the effects of nuts on different ethnic groups. Our results suggest that the health benefits and acceptability of nuts seen in predominantly Caucasian populations can be extended to Māori, the indigenous population within New Zealand.

Dietary Polyamines and Diseases: Reducing Polyamine Intake Can Be Beneficial In Cancer Treatment

Pages: 27-38
Find References

Finding References


Dietary Polyamines and Diseases: Reducing Polyamine Intake Can Be Beneficial In Cancer Treatment

Search :
Google Scholor
Search :
Microsoft Academic Search
Cite

DOI: 10.18488/journal.87/2015.2.2/87.2.27.38

Citation: 2

Nihal Buyukuslu

Export to    BibTeX   |   EndNote   |   RIS

  1. C. A. Panagiotidis, S. Artandi, K. Calame, and S. Silverstein, "Polyamines alter sequence-specific DNA-protein interaction," Nucl. Acids. Res., vol. 23, pp. 1800-1809, 1995.
  2. A. E. Pegg and R. A. Casero, "Current status of the polyamine research field," Methods Mol. Biol., vol. 720, pp. 3-35, 2011.
  3. M. Kozova, P. Kalac, and T. Pelikanova, "Contents of biologically active polyamines in chicken meat, liver, heart and skin after slaughter and their changes during meat storage and cooking," Food Chem., vol. 116, pp. 419-425, 2009.
  4. R. D. Slocum, H. E. Flores, A. W. Galston, and L. H. Weinstein, "Improved method for HPLC analysis of polyamines, agmatine and aromatic monuamines in plant tissue," Plant Physiol., vol. 89, pp. 512-517, 1989.
  5. D. Valero, D. Martinez-Romero, and M. Serrano, "The role of polyamines in the improvement of the shelf life of fruit," Trends Food Sci. Tech., vol. 13, pp. 228-234, 2002.
  6. M. T. Veciana-Nogues, A. Marine-Font, and M. C. Vidal-Carou, "Biogenic amines in fresh and canned tuna. Effects of canning on biogenic amine contents," J. Agr. Food Chem., vol. 45, pp. 4324-4332, 1997.
  7. J. Y. Wang, "Polyamines regulate expression of E-cadherin and play an important role in control of intestinal epithelial barrier function," Inflammopharm., vol. 13, pp. 91-101, 2005.
  8. M. W. Ziegler, Hahn, and P. R. Wallnofer, "Changes in biogenic amine contents during processing of several plant foods," Deutsche Lebensmittel-Rundschau (In German), vol. 90, pp. 108-112, 1994.
  9. S. Bardocz, T. J. Duguid, D. S. Brown, G. Grant, A. Pusztai, A. White, and A. Ralph, "The importance of dietary polyamines in cell regeneration and growth," Br. J. Nutr., vol. 73, pp. 819-828, 1995a.
  10. S. Bardocz, "Polyamines in food and their consequences for food quality and human health," Trends Food Sci. Tech., vol. 6, pp. 341-346, 1995b.
  11. S. Bardocz, G. Grant, D. S. Brown, A. Ralph, and A. Pusztai, "Polyamines in food—implications for growth and health," J. Nutr. Biochem., vol. 4, pp. 66-71, 1993.
  12. F. Durlu-Ozkaya, E. Alichanidis, E. Litopoulou-Tzanetaki, and N. Tunail, "Determination of biogenic amine content of beyaz cheese and biogenic amine production ability of some lactic acid bacteria," Milchwissenschaft, vol. 54, pp. 680-682, 1999.
  13. K. A. Eliassen, R. Reistad, U. Risoen, and H. F. Ronning, "Dietary polyamines," Food Chem., vol. 78, pp. 273-280, 2002.
  14. T. Hernandez-Jover, M. Izquierdo-Pulido, M. T. Veciana-Nogues, A. Marine-Font, and M. C. Vidal-Carou, "Effect of starter cultures on biogenic amine formation during fermented sausage production," J. Food Protect, vol. 60, pp. 825-830, 1997.
  15. P. Kalac, M. Krizek, T. Pelikanova, M. Langova, and O. Veskrna, "Contents of polyamines in selected foods," Food Chem., vol. 90, pp. 561-564, 2005.
  16. P. Kalac, S. Svecova, and T. Pelikanova, "Levels of biogenic amines in typical vegetable products," Food Chem., vol. 77, pp. 349-351, 2002.
  17. T. Lavizzari, M. Teresa Veciana-Nogues, S. Bover-Cid, A. Marine-Font, and M. Carmen Vidal-Carou, "Improved method for the determination of biogenic amines and polyamines in vegetable products by ion-pair high-performance liquid chromatography," J. Chromatogr. A., vol. 1129, pp. 67-72, 2006.
  18. S. Moret, D. Smela, T. Populin, and L. Conte, "A survey on free biogenic amine content of fresh and preserved vegetables," Food Chem., vol. 89, pp. 355-361, 2005.
  19. N. Nishibori, S. Fujihara, and T. Akatuki, "Amounts of polyamines in foods in Japan and intake by Japanese," Food Chem., vol. 100, pp. 491-499, 2006.
  20. K. Nishimura, R. Shiina, K. Kashiwagi, and K. Igarashi, "Decrease in polyamines with aging and their ingestion from food and drink," J. Biochem., vol. 139, pp. 81-90, 2006.
  21. S. Novella-Rodriguez, M. T. Veciana-Nogues, M. Izquierdo-Pulido, and M. C. Vidal-Carou, "Distribution of biogenic amines and polyamines in cheese," J. Food Sci., vol. 68, pp. 750-755, 2003.
  22. S. N. Novella-Rodriguez, M. T. Veciana-Nogues, A. X. Roig-Sagues, A. J. Trujillo-Mesa, and M. C. Vidal- Carou, "Evaluation of biogenic amines and microbial counts throughout the ripening of goat cheeses from pasteurized and raw milk," J. Dairy Res., vol. 71, pp. 245-252, 2004.
  23. S. Novella-Rodriguez, M. T. Veciana-Nogues, and M. C. Vidal-Carou, "Biogenic amines and polyamines in milks and cheeses by ionpair high performance liquid chromatography," J. Agric. Food Chem., vol. 48, pp. 5117-5123, 2000.
  24. A. Okamoto, E. Sugi, Y. Koizumi, F. Yanagida, and S. Udaka, "Polyamine content of ordinary food stuffs and various fermented foods," Biosci. Biotechnol. Biochem., vol. 61, pp. 1582-1586, 1997.
  25. M. Saaid, B. Saad, N. H. Hashim, A. S. M. Ali, and M. I. Saleh, "Determination of biogenic amines in selected Malaysian food," Food Chem., vol. 113, pp. 1356-1362, 2009.
  26. C. M. G. Silva and M. B. A. Gloria, "Bioactive amines in chicken breast and thigh after slaughter and during storage at 4 ± 1 °C and in chicken-based meat products," Food Chem., vol. 78, pp. 241-249, 2002.
  27. K. Valsamaki, A. Michaelidou, and A. Polychroniadou, "Biogenic amine production in feta chees," Food Chem., vol. 71, pp. 259-266, 2000.
  28. Y. J. Xu, T. Hara, K. Samejima, H. Sasaki, M. Kobayashi, A. Takahashi, and M. Niitsu, "Simultaneous determination of endogenous and orally administered 15n-labeled polyamines in rat organs," Anal. Biochem., vol. 301, pp. 255-260, 2002.
  29. M. A. Ali, E. Poortvliet, R. Stromberg, and A. Yngve, "Polyamines in foods: Development of a food database," Food Nutr. Res., vol. 55. DOI: 10.3402/fnr.v55i0.5472, 2011.
  30. N. Buyukuslu, H. Hizli, K. Esin, and M. Garipagaoglu, "A cross-sectional study: Nutritional polyamines in frequently consumed foods of the Turkish population," Foods, vol. 3, pp. 541-557, 2014.
  31. A. Ralph, K. Englyst, and S. Bardocz, Polyamine content of the human diet. In polyamines in health and nutrition. Bardocz, S., White, A., (Eds). London, UK: Kluwer Academic Publishers, 1999.
  32. C. Zoumas-Morse, C. L. Rock, E. L. Quintana, M. L. Neuhouser, E. W. Gerner, and F. L. Meyskens, "Development of a polyamine database for assessing dietary intake," J. Am. Diet. Assoc., vol. 107, pp. 1024-1027, 2007.
  33. R. A. Casero and L. J. Marton, "Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases," Nat. Rev. Drug Discov., vol. 6, pp. 373-390, 2007.
  34. E. W. Gerner and F. L. Meyskens, "Polyamines and cancer: Old molecules, new understanding," Nat. Rev. Cancer., vol. 4, pp. 781-792, 2004.
  35. N. Babbar, T. Murray-Stewart, and R. A. Casero, "Inflammation and polyamine catabolism: The good, the bad and the ugly," Biochem Soc. Trans., vol. 35, pp. 300-304, 2007.
  36. H. Tomitori, T. Usui, N. Saeki, S. Ueda, H. Kase, K. Nishimura, K. Kashiwagi, and K. Igarashi, "Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke," Stroke, vol. 36, pp. 2609-2613, 2005.
  37. M. Yoshida, K. Higashi, E. Kobayashi, N. Saeki, K. Wakui, T. Kusaka, H. Takizawa, K. Kashiwado, N. Suzuki, K. Fukuda, T. Nakamura, K. Watanabe, S. Tada, Y. Machi, M. Mizoi, T. Toida, T. Kanzaki, H. Tomitori, K. Kashiwagi, and K. Igarashi, "Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP," Atherosclerosis, vol. 211, pp. 475-479, 2010.
  38. K. Igarashi and K. Kashiwagi, "Use of polyamine metabolites as markers for stroke and renal failure," Methods Mol. Biol., vol. 720, pp. 395-408, 2011.
  39. D. L. Kramer, P. Diegelman, J. Jell, S. Vujcic, S. Merali, and C. W. Porter, "Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences " J. Biol. Chem., vol. 283, pp. 4241-4251, 2008.
  40. P. Kalac, "Health effects and occurrence of dietary polyamines: A review for the period 2005 mid 2013," Food Chem., vol. 161, pp. 27-39, 2014.
  41. R. A. Casero and A. E. Pegg, "Polyamine catabolism and disease," Biochem. J., vol. 421, pp. 323-338, 2009.
  42. E. W. Gerner, "Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models," Biochem Soc. Trans., vol. 35, pp. 322-325, 2007.
  43. S. L. Nowotorski, P. M. Woster, and R. A. Casero, "Polyamines and cancer: Implications for chemoprevention and chemotherapy," Expert Rev. Mol. Med., vol. 15, p. e3, 2013.
  44. A. E. Pegg, "Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy," Cancer Res., vol. 48, pp. 759-774, 1988.
  45. D. H. Rusel, "Increased polyamine concentrations in the urine of human cancer patients," Nature, vol. 23, pp. 144-145, 1971.
  46. D. Russell and S. H. Snyder, "Amine synthesis in rapidly growing tissues: Ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors," Proc. Natl. Acad. Sci. USA., vol. 60, pp. 1420-1427, 1968.
  47. V. Battaglia, C. DeStefano Shields, T. Murray-Stewart, and R. A. Casero, "Polyamine catabolism in carcinogenesis: Potential targetsfor chemotherapy and chemoprevention," Amino Acids, vol. 46, pp. 511-519, 2014.
  48. D. H. Rusel, "Clinical relevance of polyamines as biochemical markers of tumor kinetics," Clin. Chem., vol. 23, pp. 22-27, 1977.
  49. A. Bardia, E. A. Platz, S. Yegnasubramanian, A. M. De Marzo, and W. G. Nelson, "Anti-inflammatory drugs, antioxidants, and prostate cancer prevention," Curr. Opin. Pharmacol., vol. 9, pp. 419-426, 2009.
  50. N. De Vera, E. Martinez, and C. Sanfeliu, "Spermine induces cell death in cultured human embryonic cerebral cortical neurons through N-methyl-D-aspartate receptor activation," J. Neurosci. Res., vol. 86, pp. 861-872, 2008.
  51. T. Tanaka, "Preclinical cancer chemoprevention studies using animal model of inflammation-associated colorectal carcinogenesis," Cancers, vol. 4, pp. 673-700, 2012.
  52. K. Soda, Polyamines - The principal candidate substance of soybean-induced health, soybean and health. Prof. Hany El-Shemy (Eds.), ISBN: 978-953-307-535-8, InTech, DOI: 10.5772/17715, 2011.
  53. R. Das and M. S. Kanungo, "Activity and modulation of ornithine decarboxylase and concentrations of polyamines in various tissues of rats as a function of age," Exp. Geront., vol. 17, pp. 95-103, 1982.
  54. M. Kaeberlein, "Spermidine surprise for a long life," Nat. Cell Biol., vol. 11, pp. 1277-1278, 2009.
  55. N. Minois, P. Rockenfeller, T. K. Smith, and D. Carmona-Gutierrez, "Spermidine feeding decreases age-related locomotor activity loss and induces changes in lipid composition," PLoSOne, vol. 9, p. e102435, 2014.
  56. P. N. T. Binh, K. Soda, and M. Kawakami, "Mediterranean diet and polyamine intake: Possible contribution of increased polyamine intake to inhibition of age-associated disease," Nutr. Diet Suppl., vol. 3, pp. 1-7, 2011.
  57. T. J. LaRocca, R. A. Gioscia-Ryan, C. M. Hearon, and D. R. Seals, "The autophagy enhancer spermidine reverses arterial aging," Mech. Ageing. Dev., vol. 134, pp. 314-320, 2013.
  58. J. H. Gao, L. J. Guo, Z. Y. Huang, J. N. Rao, and C. W. Tang, "Roles of cellular polyamines in mucosal healing in the gastrointestinal tract," J. Physiol. Pharmacol., vol. 64, pp. 681-693, 2013.
  59. N. Seiler and F. Raul, "Polyamines and the intestinal tract," Crit. Rev. Clin. Lab. Sci., vol. 44, pp. 365-411, 2007.
  60. J. Timmons, E. T. Chang, J. Y. Wang, and J. N. Rao, "Polyamines and gut mucosal homeostasis," J. Gastrointest. Dig. Syst., vol. 20, p. 001, 2012.
  61. C. V. Lagishetty and S. R. Naik, "Polyamines: Potential anti-inflammatory agents and their possible mechanism of action," Indian J. Pharmacol., vol. 40, pp. 121-125, 2008.
  62. R. Kibe, S. Kurihara, Y. Sakai, H. Suzuki, T. Ooga, E. Sawaki, K. Muramatsu, A. Nakamura, A. Yamashita, Y. Kitada, M. Kakeyama, Y. Benno, and M. Matsumoto, "Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice," Sci. Rep., vol. 1, p. 4548, 2014.
  63. A. Orlando, M. Linsalata, M. Notarnicola, V. Tutino, and F. Russo, "Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: The role of cellular polyamines," BMC Microbiol., vol. 14, p. 19, 2014.
  64. S. Y. Wang and M. Faust, "Comparison of seasonal growth and polyamine content in shoots of orchard-grown standard and genetic dwarf apple trees," Physiol Plantarum., vol. 89, pp. 376-380, 1993.
  65. G. Michaelsson, B. Gerden, E. Hagforsen, B. Nilsson, I. Pihl-Lundin, W. Kraaz, G. Hjelmquist, and L. Lööf, "Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet," Br. J. Dermatol., vol. 142, pp. 44-51, 2000.
  66. V. Broshtilova, V. Lozanov, and L. Miteva, "Polyamine metabolism changes in psoriasis," Indian J. Dermatol., vol. 58, pp. 306-309, 2013.
  67. A. Gugliucci and T. Menini, "The polyamines spermine and spermidine protect proteins from structural and functional damage by AGE precursors: A new role for old molecules?," Life Sci., vol. 72, pp. 2603-2616, 2003.
  68. R. H. S. Ahmad, K. Moinuddin, and A. Ali, "Physicochemical studies on glycation-induced structural changes in human IgG," IUBMB Life, vol. 64, pp. 151-156, 2012.
  69. A. R. Hipkiss, "Glycation, ageing and carnosine: Are carnivorous diets beneficial?," Mech. Ageing. Dev., vol. 126, pp. 1034-1039, 2005.
  70. M. G. Makletsova, T. N. Fedorova, M. Y. Maksimova, and A. A. Boldyrev, "Effects of carnosine on polyamine levels in red blood cells of patients with hypertonic discirculatory encephalopathy," Bull. Exp. Biol. Med., vol. 154, pp. 210-212, 2012.
  71. R. Seidl, S. Beninati, N. Cairns, N. Singewald, D. Risser, H. Bavan, M. Nemethova, and G. Lubec, "Polyamines in frontal cortex of patients with down syndrome and alzheimer disease," Neurosci. Lett., vol. 206, pp. 193-195, 1996.
  72. A. L. Cason, Y. Ikeguchi, C. Skinner, T. C. Wood, H. A. Lubs, F. Martinez, R. J. Simensen, R. E. Stevenson, A. E. Pegg, and C. E. Schwartz, "X-Linked spermine synthase gene (SMS) defect: The first polyamine deficiency syndrome," Eur. J. Hum. Genet., vol. 11, pp. 937-944, 2003.
  73. A. E. Pegg, "Mammalian polyamine metabolism and function," IUBMB Life, vol. 61, pp. 880-894, 2009.
  74. P. Kalac and P. Krausova, "A review of dietary polyamines: Formation, implications for growth and health and occurrence in foods," Food Chem., vol. 90, pp. 219-230, 2004.
  75. J. K. Stechmiller, B. Childress, and L. Cowan, "Arginine supplementation and wound healing," Nutr. Clin. Pract., vol. 20, pp. 52-61, 2005.
  76. L. Alhonen, J. J. Parkkinen, T. Keinanen, R. Sinervirta, K. H. Herzig, and J. Janne, "Activation of polyamine catabolism in transgenic rats induces acute pancreatitis," Proc. Natl. Acad. Sci. U S A, vol. 97, pp. 8290-8295, 2000.
  77. S. Sarhan, B. Knodgen, and N. Seiler, "The gastrointestinal tract as polyamine source for tumor growth," Anticancer Res., vol. 9, pp. 215-223, 1989.
  78. F. L. Meyskens and E. W. Gerner, "Development of difluoromethylornithine (DFMO) as a chemoprevention agent," Clin. Cancer Res., vol. 5, pp. 945-951, 1999.
  79. C. S. Hayesa, M. R. Burnsb, and S. K. Gilmour, "Polyamine blockade promotes antitumor immunity," OncoImmunol., vol. 3, p. e27360, 2014.
  80. B. G. Cipolla, R. Havouis, and J. P. Moulinoux, "Polyamine contents in current foods: A basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients," Amino Acids, vol. 33, pp. 203-212, 2007.
  81. B. Cipolla, J. Y. Bansard, J. P. Ecalard, and J. P. Moulinoux, "Treating metastatic castration-resistant prostate cancer with novel polyamine-free oral nutritional supplementation: Phase I study," BioMed., vol. 3, pp. 114-119, 2013.
  82. R. F. Bell, J. Borzan, and G. E. Kalso, "Simonnet, food, pain, and drugs: Does it matter what pain patients eat?," Pain, vol. 153, pp. 1993-1996, 2012.
  83. C. Rivat, P. Richebe, E. Laboureyras, J. P. Laulin, R. Havouis, F. Noble, J. P. Moulinoux, and G. Simonnet, "Polyamine deficient diet to relieve pain hypersensitivity," Pain, vol. 137, pp. 125-137, 2008.
  84. J. P. Estebe, F. Legay, M. Gentili, E. Wodey, C. Leduc, C. Ecoffey, and J. P. Moulinoux, "An evaluation of a polyamine-deficient diet for the treatment of inflammatory pain," Anesth Analg, vol. 102, pp. 1781-1788, 2006.
  85. J. Ferrier, M. Bayet-Robert, B. Pereira, L. Daulhac, A. Eschalier, D. Pezet, J. P. Moulinoux, and D. Balayssac, "A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats," PLoS ONE, vol. 8, p. e77828, 2013.
  86. C. Löser, A. Eisel, D. Harms, and U. R. Fölsch, "Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development," Gut., vol. 44, pp. 12-16, 1999.
  87. K. Nishimura, T. Yanase, H. Nakagawa, S. Matsuo, Y. Ohnishi, and S. Yamasaki, "Effect of polyamine-deficient chow on trypanosoma brucei brucei infection in rats," J Parasitol., vol. 95, pp. 781-786, 2009.
  88. K. P. Raj, J. A. Zell, C. L. Rock, C. E. McLaren, C. Zoumas-Morse, E. W. Gerner, and F. L. Meyskens, "Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas," Br. J. Cancer, vol. 108, pp. 512-518, 2013.
  89. B. G. Cipolla, R. Havouis, and J. P. Moulinoux, "Polyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients," Biomed Pharmacother, vol. 64, pp. 363-368, 2010.
  90. M. Linsalata and F. Russo, "Nutritional factors and polyamine metabolism in colorectal cancer," Nutr., vol. 24, pp. 382-389, 2008.
  91. A. J. Vargas, B. C. Wertheim, E. W. Gerner, C. A. Thomson, C. L. Rock, and P. A. Thompson, "Dietary polyamine intake and risk of colorectal adenomatous polyps," Am. J. Clin. Nutr., vol. 96, pp. 133-141, 2012.
Nihal Buyukuslu (2015). Dietary Polyamines and Diseases: Reducing Polyamine Intake Can Be Beneficial In Cancer Treatment. Journal of Nutrients, 2(2): 27-38. DOI: 10.18488/journal.87/2015.2.2/87.2.27.38
Polyamines are most abundant polycationic natural amines and involved in several physiological processes. They can be supplied by the endogenous synthesis inside the cell or by the intake from exogenous sources.  The polyamine content of cells is regulated by biosynthesis, degradation, uptake and excretion. The benefits of dietary polyamines can be changed; they may be harmful, neutral or beneficial. For example, increasing the amount of dietary polyamines is suggested during rapid growth, such as during the neonatal period, wound healing and after surgery. However, in cancer patients, reducing polyamine dietary intake has been shown to be beneficial on the quality of life.  This review aimed to evaluate the effect of dietary polyamines in health and disease.
Contribution/ Originality
This study contributes in the existing literature by providing a detailed information on the importance of dietary polyamines in health and diseases. This study also highlights the beneficial impact of low polyamine diet on cancer treatment, and helps to increase awareness of daily polyamine intake regarding individual requirements.